| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |